Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD-Reference-Cited by-同舟云学术

Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD

Published:2024-05 Issue: Volume: Page:
ISSN:0016-5107
Container-title:Gastrointestinal Endoscopy
language:en
Short-container-title:Gastrointestinal Endoscopy

Author:

Chapman Malcolm B.,Norwood Dalton A.^ORCID,Price Christopher,Abdulhadi Basma,Kyanam Kabir Baig Kondal,Ahmed Ali M.,Peter Shajan,Routman Justin S.,Sánchez-Luna Sergio A.,Duggan Elizabeth W.,Mulki Ramzi

Publisher

Elsevier BV

Reference10 articles.

1. Tirzepatide once weekly for the treatment of obesity;Jastreboff;N Engl J Med,2022

2. Incretins in obesity and diabetes;Chia;Ann N Y Acad Sci,2020

3. Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide;Sherwin;Can J Anaesth,2023

4. Impact of glucagon-like peptide-1 receptor agonists (GLP-1RA) on food content during esophagogastroduodenoscopy (EGD);Stark;Ann Pharmacother,2022

5. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults;van Can;Int J Obesity,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Impact of GLP-1 Receptor Agonists on Endoscopic Patient Outcomes in an Ambulatory Setting: A Retrospective Study at a Large Tertiary Center;Journal of Clinical Medicine;2024-09-12

2. Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Endoscopy: A Meta-Analysis;Clinical Gastroenterology and Hepatology;2024-08